Mukka Proteins Expands Bengaluru Waste-to-Value Business With Black Soldier Fly Technology
Mukka Proteins Limited is expanding its presence in the circular bio-economy with a plan to convert Bengaluru’s municipal wet waste into high-value products including insect protein meal, insect oil, organic compost and humic acid.
The company announced its commercial roadmap and operational capacities on September 1, 2026, highlighting the potential to scale its Bengaluru wet-waste processing operations from the current 200 tonnes per day (TPD) to 1,000 TPD by December 2027.
The initiative uses automated Black Soldier Fly (BSF) bioconversion technology to transform biodegradable organic waste into marketable bio-products.
Mukka Proteins’ Bengaluru Waste Processing Plan
Mukka Proteins currently has an intake capacity of approximately 200 TPD at its Bengaluru operations.
According to the company’s roadmap:
- Current intake: 200 TPD
- Target by March 2027: 400 TPD
- Target by December 2027: 1,000 TPD
The company describes the infrastructure as modular and scalable, allowing processing capacity to be increased in phases as municipal waste intake expands.
How Black Soldier Fly Technology Works
The company uses the larval stage of the Black Soldier Fly (Hermetia illucens) to process organic waste.
According to Mukka Proteins, the process can achieve approximately 80% mass reduction of raw organic waste within a 10-14 day cycle.
Instead of sending biodegradable waste to conventional landfill disposal, the process converts organic material into usable biomass and several commercially valuable products.
Four Potential Revenue Streams
Mukka Proteins plans to generate value from the waste stream through four key product categories.
1. Insect Protein Meal
The company says its insect protein meal can contain more than 50% crude protein and has an amino-acid profile suitable for animal nutrition applications.
Potential markets include:
- Aquaculture feed
- Poultry feed
- Pet food
- Fishmeal replacement
- Soybean meal replacement
The growing demand for alternative protein sources could create opportunities for insect-based protein products in the animal nutrition industry.
2. Insect Oil
The bioconversion process also produces insect oil containing medium-chain triglycerides and lauric acid.
The company identifies potential applications in:
- Animal nutrition
- Gut-health formulations
- Specialized feed products
- Oleochemical applications
This creates another potential revenue stream from the same organic waste input.
3. Organic Frass Compost
The residual material, known as insect frass, can be processed into organic compost.
Mukka Proteins says the product contains natural chitin and can support beneficial soil microorganisms while improving soil structure.
The product could potentially benefit from growing interest in organic farming and biological soil-health solutions.
4. Humic Acid and Bio-Stimulants
The company also plans to produce humic acid and other bio-stimulants through post-digestion bio-refining.
These products are positioned as agricultural inputs that can improve crop nutrient absorption and soil conditioning.
Bengaluru’s Large Wet-Waste Opportunity
Bengaluru generates more than 4,000 metric tonnes of solid waste every day, according to the company’s release.
Mukka estimates that approximately 50%-60% of this waste consists of biodegradable wet waste.
This creates a significant potential feedstock opportunity for waste-processing technologies.
Traditional disposal methods can create environmental challenges, including methane emissions and groundwater contamination risks.
Mukka’s proposed model aims to convert part of this waste stream into commercial products instead.
Existing Manufacturing Base Provides Support
The Bengaluru initiative complements Mukka Proteins’ existing animal nutrition business.
The company states that it has more than 291,720 MTPA of conventional marine protein and oil processing capacity across India and Oman.
Mukka also has an export presence across more than 25 countries.
This existing infrastructure could provide the company with supply-chain capabilities, customer relationships and international market access as it develops its insect-protein and bio-economy business.
Global Market Opportunity
Mukka Proteins sees opportunities in both domestic and international markets.
The company estimates that the global insect meal and lipid market could exceed $3.5 billion by 2030, driven by demand for alternative protein sources in European and Asian feed markets.
In India, potential demand could come from aquaculture, poultry and the rapidly developing pet-food industry.
The company also points to opportunities in organic fertilizers and bio-stimulants as agriculture increasingly focuses on soil health and sustainable inputs.
Carbon Credits and ESG Opportunity
Another potential component of the business is carbon credits.
By diverting organic waste away from landfill environments and processing it through biological conversion, Mukka Proteins says the operations could help reduce greenhouse-gas emissions.
The company also states that its facilities are being integrated with global carbon-credit verification frameworks, including Verra registry standards.
If successfully implemented and verified, carbon credits could provide an additional revenue stream while strengthening the company’s environmental, social and governance positioning.
Why This Development Matters for Investors
The announcement represents a potential strategic expansion for Mukka Proteins beyond its traditional fishmeal and fish-oil business.
The company’s existing animal nutrition operations provide a foundation, while the Bengaluru project introduces exposure to several emerging themes:
- Circular economy
- Waste-to-value businesses
- Alternative proteins
- Sustainable animal nutrition
- Organic agriculture
- Bio-stimulants
- Carbon credits
- Urban waste management
The key factor for investors will be execution and commercial scalability.
Moving from 200 TPD currently to 400 TPD by March 2027 and eventually 1,000 TPD by December 2027 would represent a substantial increase in processing capacity.
Investors will therefore need to monitor actual capacity additions, municipal waste contracts, product realisations, operating costs, customer demand and the contribution of these new businesses to Mukka Proteins’ financial performance.
Mukka Proteins: Key Things to Watch
The Bengaluru project is still an evolving growth initiative, and several milestones will be important going forward.
Investors can watch for:
Capacity expansion: Whether the company achieves its planned 400 TPD and 1,000 TPD milestones.
Commercialisation: The scale at which insect protein, oil, compost and humic acid begin generating meaningful revenue.
Margins: Whether the waste-to-value products can generate attractive margins after processing and logistics costs.
Municipal partnerships: The development and stability of municipal waste supply arrangements.
Carbon credits: Progress toward verification and monetisation of potential carbon-credit opportunities.
Customer adoption: Demand from aquaculture, poultry, pet food and agricultural customers.
Investor Takeaway
Mukka Proteins’ Bengaluru initiative combines urban waste management with animal nutrition and sustainable agriculture, creating a potentially diversified waste-to-value business model.
The company’s plan to scale processing from 200 TPD to as much as 1,000 TPD by December 2027 is ambitious and could significantly expand the project’s potential if execution remains on track.
However, investors should distinguish between the company’s stated market opportunity and realised financial performance. The project will need to demonstrate successful capacity expansion, consistent raw-material availability, customer adoption and profitable commercial operations.
For Mukka Proteins shareholders, the Bengaluru project is therefore a long-term growth opportunity to monitor, rather than a development whose full financial impact can yet be determined.
Source: Mukka Proteins Limited press release dated September 1, 2026. The market-size figures, capacity targets and forward-looking statements are based on information provided by the company and should not be treated as guaranteed outcomes.